COMPOSITION FOR DIAGNOSING OVARIAN CANCER METASTASIS BY USING CPG METHYLATION IN GENE, AND USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160265061A1
SERIAL NO

14433397

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a composition, a kit and a method for diagnosing ovarian cancer metastasis or predicting risk of the metastasis by detecting methylation levels at CpG sites of one or more genes selected from the group consisting of ADAM12 (a disintegrin and metalloproteinase 12), NTN4 (netrin 4), and PTGS2 (prostaglandin-endoperoxide synthase 2).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATIONEWHA WOMANS UNIVERSITY DAEHYUN-DONG 52 EWHAYEODAE-GIL SEODAEMUN-GU SEOUL 120-750

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
AHN, Jung-Hyuck Seoul, KR 3 0
JU, Woong Seoul, KR 2 0
SUNG, Hye-Youn Seoul, KR 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation